RT Journal Article
SR Electronic
T1 Working from a distance: Who can afford to stay home during COVID-19? Evidence from mobile device data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.20.20153577
DO 10.1101/2020.07.20.20153577
A1 Christine Dimke
A1 Marissa Lee
A1 Jude Bayham
YR 2020
UL http://medrxiv.org/content/early/2020/07/26/2020.07.20.20153577.abstract
AB As the COVID-19 pandemic continues, local and state governments must weigh the costs and benefits of social distancing policy. However, the effectiveness of such policies depend on individuals’ willingness and ability to comply. We propose a simple method to infer sociodemographic heterogeneity in social distancing as measured by Safegraph mobile device data. We document evidence that people’s ability to work from home is a determinant of time spent at home since the beginning of the pandemic. On April 15th, census block groups that are more likely able to work from home spent 3 more hours at home compared to those who were not. We see supporting trends among block groups with differences in income and educational attainment.JEL J19, J69, Z00Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We acknowledge support from Amazon Web Services Diagnostic Development Initiative. We thank SafeGraph (www.safegraph.com) for generously providing data.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approvals were obtained due to the secondary nature of the data they were unnecessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAs stated in the manuscript Safegraph compilation of ACS data is available for download free of charge. The mobility data can be licensed from Safegraph. Data processing code can be found in the repository linked. https://github.com/cdimke/work_from_home